MSACL 2024Monterey, CA : March 17-22 |
|
MSACL 2024
14th Annual Conference & Exhibits
Monterey, CA
March 17 - 22, 2024
|
|
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Mass Spectrometry & Advances in the Clinical Lab (MSACL). University of Nebraska Medical Center
is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing
education for the healthcare team.
The University of Nebraska Medical Center designates this live activity for a maximum of 33.45 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
You will receive a link with instructions to claim your CME credits upon completion of the conference feedback questionnaire.
IMPORTANT : You will have only 20 days to claim your credits. There is zero flexibility on this.
More info on CME Accreditation at MSACL here.
MSACL's mission is to support the community in overcoming the challenges of implementing high value tests in the clinical lab.
MSACL is focused on providing a forum of interaction for participants in all stages of the development, advancement and use of analytical tools, including data analytics, in the clinic to improve patient care. Although the group primarily focuses on mass spectrometry, presentations and discussion on other platforms are welcome.
The Monterey Conference Center (MCC) is flanked by two hotels, the Marriott, and the Portola. Each has meeting space and their own restaurant. Local sourcing is a priority. Portola also has a brewpub (Peter B’s).
We will be using the Monterey Conference Center’s Serra Ballroom as the MSACL Exhibit Hall (19,150 square feet). There will be space for at ~34 booths interspersed with up to 172 posters.
We had 530 attendees for MSACL 2023. We are expecting about 580-650 for MSACL 2024.
Personal Accountability Commitment
By attending the MSACL 2024 you agree to abide by and engage in conduct that is beneficial to health and safety while at the event.
Health Recommendations
MSACL strongly recommends all meeting attendees do the following:
- Stay up to date with COVID-19 and other recommended adult vaccinations.
- Take a rapid COVID-19 test prior to attending the meeting and do not attend if you test positive.
- Do not attend the meeting if you have symptoms that could be consistent with a cold or other respiratory infection.
- Leave the meeting if you develop such symptoms.
- Wear a mask in crowded indoor settings in the convention center, hotels, and aboard the hotel shuttles.
MSACL invests heavily in education via the MSACL Educational Grants, which support conference attendance:
In the past we have had specific tracks for each -omic topic area. For 2024, we are planning to focus on plenary sessions with panel discussions that bring the community together, in addition to parallel sessions on focused topics.
A list of the topics being solicited for the current conference is below.
Abstract Submission Categories for MSACL 2024
The target audience for this program includes pathologists, clinical laboratory directors and scientists, mass spectrometry and automated sample processing providers as well as laboratory diagnostic providers. This program will be beneficial to healthcare administrators, laboratory quality control and standards scientists, as well as those responsible for implementation of clinical analyses for emergency response due to terrorism or accident.
With the advancement of technologies for clinical analysis, there exists a gap between those who understand the technology and those who do not. Without continual education, this gap will grow and these advancements are unlikely to be effectively incorporated into the clinical analysis workflow, resulting in lost opportunities to improve patient outcomes and reduce healthcare costs.
MSACL provides an environment through which participants will be able to identify opportunities to develop the capacity to provide higher quality results, more rapidly and for lower overall cost, for patients within the healthcare system.